A genetic variation of SOD2 does not determine duration of response to androgen deprivation therapy for prostate cancer

BACKGROUND: Silencing SOD2 expression up-regulates AR signaling and expression of SOD2 is down-regulated in CRPC, compared with untreated tumors. The decreased SOD2 activity could lead to AR gain-of-function and the development of castration-resistance. METHOD: We genotyped SOD2-rs4880 in a cohort o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Prostate
Главные авторы: Xie, Wanling, Drouin, Sarah, Nakabayashi, Mari, Pomerantz, Mark, Lee, Gwo-Shu Mary, Kantoff, Philip W., Sharifi, Nima
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5637518/
https://ncbi.nlm.nih.gov/pubmed/27325180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23220
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы